These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37997952)

  • 1. Rational design of thiazolidine-4-one-gallic acid hybrid derivatives as selective partial PPARγ modulators: an in-silico approach for type 2 diabetes treatment.
    Aryan ; Babu B; Divakar S; Gowramma B; Jupudi S; Chand J; Malakar Kumar V
    J Biomol Struct Dyn; 2023 Nov; ():1-15. PubMed ID: 37997952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational investigation of phytochemicals from
    Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
    J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists.
    Najmi A; Alam MS; Thangavel N; Taha MME; Meraya AM; Albratty M; Alhazmi HA; Ahsan W; Haque A; Azam F
    Sci Rep; 2023 Nov; 13(1):19869. PubMed ID: 37963936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ).
    Wang J; Wang B; Zhang Y
    J Biomol Struct Dyn; 2020 Feb; 38(2):398-409. PubMed ID: 31025599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study.
    Gangadhariah M; Pardhi T; Ravilla J; Chandra S; Singh SA
    J Biomol Struct Dyn; 2023; 41(21):11373-11393. PubMed ID: 36576222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat.
    Mandal SK; Kumar BK; Sharma PK; Murugesan S; Deepa PR
    Comput Biol Med; 2022 Aug; 147():105796. PubMed ID: 35809408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands.
    Mottin M; Souza PC; Ricci CG; Skaf MS
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico approach for the discovery of new PPARγ modulators among plant-derived polyphenols.
    Encinar JA; Fernández-Ballester G; Galiano-Ibarra V; Micol V
    Drug Des Devel Ther; 2015; 9():5877-95. PubMed ID: 26604687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
    Muralikumar S; Vetrivel U; Narayanasamy A; N Das U
    Lipids Health Dis; 2017 Jan; 16(1):17. PubMed ID: 28109294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INT131: a selective modulator of PPAR gamma.
    Motani A; Wang Z; Weiszmann J; McGee LR; Lee G; Liu Q; Staunton J; Fang Z; Fuentes H; Lindstrom M; Liu J; Biermann DH; Jaen J; Walker NP; Learned RM; Chen JL; Li Y
    J Mol Biol; 2009 Mar; 386(5):1301-11. PubMed ID: 19452630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
    Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
    J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
    Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
    J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering PPAR-γ agonists: An integrated computational approach driven by machine learning.
    Haider S; Shafiq M; Siddiqui AR; Sardar M; Mushtaq M; Shafeeq S; Nur-E-Alam M; Ahmad A; Ul-Haq Z
    J Mol Graph Model; 2024 Jun; 129():108742. PubMed ID: 38422823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of phytochemicals as putative ligands for the targeted modulation of peroxisome proliferator-activated receptor α (PPARα) in animals.
    Hassan FU; Rehman MS; Javed M; Ahmad K; Fatima I; Safdar M; Ashraf N; Nadeem A
    J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37837423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
    Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
    J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of HDAC8-ligands' intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents.
    Dewaker V; Srivastava AK; Arora A; Prabhakar YS
    J Biomol Struct Dyn; 2021 Aug; 39(13):4726-4751. PubMed ID: 32578494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational study to identify the key residues of peroxisome proliferator-activated receptor gamma in the interactions with its antagonists.
    Sharifi T; Ghayeb Y
    J Biomol Struct Dyn; 2018 May; 36(7):1822-1833. PubMed ID: 28566016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Selective PPAR-γ Modulators by Combining Pharmacophore Modeling, Molecular Docking, and Adipogenesis Assay.
    Li Y; Ks N; Byran G; Krishnamurthy PT
    Appl Biochem Biotechnol; 2023 Feb; 195(2):1014-1041. PubMed ID: 36264481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
    Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
    Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.